Malloy to receive CTC honor

The Connecticut Technology Council will present its 2013 Public Policy Leadership award to Gov. Dannel Malloy at its annual meeting on Thursday at Fairfield University.
Malloy and his administration have consistently supported the CTC’s legislative efforts, according to the CTC, shaping his economic development efforts in part by allocating several millions of dollars in support of growing the state’s tech sector.
A variety of programs now provide funding to various non-profit agencies who are contracted with to provide services to both start-ups and maturer companies called “stage II” companies. Connecticut Innovations, the state’s investment arm for strategic capital investments in the high tech sector, has been given substantially more funding to increase its deal activity, according to the CTC, noting that the CTC has been a proponent of making more capital available to CI.
The CTC will also present its annual Innovation Excellence Award to member company Alexion Pharmaceuticals. New Haven-based Alexion, a public company, is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening diseases that are also ultra-rare.
Its first commercial product, Soliris (eculizumab), is the world’s first and only approved terminal complement inhibitor and is approved in nearly 50 countries as a treatment for patients with paroxysmal nocturnal hemoglobinuria, and in the United States, European Union, Japan and other countries as a treatment for patients with atypical hemolytic uremic syndrome.
The CTC membership will also elect new board members Thursday.